ناشر تخصصی کنفرانس های ایران

لطفا کمی صبر نمایید

Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

The effects of Allium cepa L. (onion) and its active constituents on metabolic syndrome: A review

Year: 1400
COI: JR_IJBMS-24-1_002
Language: EnglishView: 125
This Paper With 14 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 14 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Amin Galavi - School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Hossein Hosseinzadeh - Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Bibi Marjan Razavi - Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract:

Metabolic syndrome as a clustering disorder includes excess abdominal fat distribution, abnormal insulin and glucose metabolism, disturbed blood lipids, pro-inflammatory state, and hypertension. Regarding to the adverse effects of synthetic medicines, the identification of appropriate healthcare approaches, such as herbal medicines, with fewer side effects is more favorable. Allium cepa L. (onion) is a culinary and medicinal herb belonging to the family of Amaryllidaceae. Flavonoids such as quercetin and kaempferol, alk(en)yl cysteine sulfoxides including S-methyl cysteine sulfoxide and S-propyl cysteine sulfoxide, cycloalliin, thiosulfinates, and sulfides are main compounds existing in the plant. A. cepa and its pharmacologically active constituents display broad-spectrum activities including anti-oxidant, anti-inflammatory, lipid-modifying, anti-obesity, antihypertensive, and antidiabetic effects. Our objective in this review was to find out the role of A. cepa and its bioactive phytochemicals as cardiovascular protective agents in different metabolic syndrome risk factors, including hyperlipidemia, high blood glucose, obesity, and hypertension.

Keywords:

Paper COI Code

This Paper COI Code is JR_IJBMS-24-1_002. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1138564/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Galavi, Amin and Hosseinzadeh, Hossein and Razavi, Bibi Marjan,1400,The effects of Allium cepa L. (onion) and its active constituents on metabolic syndrome: A review,https://civilica.com/doc/1138564

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • 1. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin ...
  • 2. Mottillo S, Filion KB, Genest J, Joseph L, Pilote ...
  • 3. GBD 2017 Causes of Death Collaborators. Global, regional, and ...
  • 4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel ...
  • 5. Ekor M. The growing use of herbal medicines: issues ...
  • 6. Teshika JD, Zakariyyah AM, Zaynab T, Zengin G, Rengasamy ...
  • 7. Upadhyay RK. Nutraceutical, pharmaceutical and therapeutic uses of Allium ...
  • 8. Ahmed N, Mahmood A, Ashraf A, Bano A, Tahir ...
  • 9. Josabad Alonso-Castro A, Jose Maldonado-Miranda J, Zarate-Martinez A, Jacobo-Salcedo ...
  • 10. Ayyanar M, Ignacimuthu S. Ethnobotanical survey of medicinal plants ...
  • 11. Prakash D, Singh BN, Upadhyay G. Anti-oxidant and free ...
  • 12. Breu W. Allium cepa L. (onion) Part 1: Chemistry ...
  • 13. Lee B, Jung JH, Kim HS. Assessment of red ...
  • 14. Ren KW, Li YH, Wu G, Ren JZ, Lu ...
  • 15. Wang R, Yang L, Li S, Ye D, Yang ...
  • 16. Draelos ZD. The ability of onion extract gel to ...
  • 17. Peng Z, Gong X, Yang Y, Huang L, Zhang ...
  • 18. Ro JY, Ryu JH, Park HJ, Cho HJ. Onion ...
  • 19. Lee SM, Moon J, Chung JH, Cha YJ, Shin ...
  • 20. Kumar VP, Venkatesh YP. Alleviation of cyclophosphamide-induced immunosuppression in ...
  • 21. Khajah MA, Orabi KY, Hawai S, Sary HG, El-Hashim ...
  • 22. Reddy RRL, Srinivasan K. Dietary fenugreek and onion attenuate ...
  • 23. Singh T, Goel RK. Neuroprotective effect of Allium cepa ...
  • 24. Kim JH. Antibacterial action of onion (Allium cepa L.) ...
  • 25. Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, Moghadasi B, Ghajari ...
  • 26. Kaiser P, Youssouf MS, Tasduq SA, Singh S, Sharma ...
  • 27. Oliveira TT, Campos KM, Cerqueira-Lima AT, Cana Brasil Carneiro ...
  • 28. Haidari F, Rashidi MR, Keshavarz SA, Mahboob SA, Eshraghian ...
  • 29. Samad N, Saleem A. Administration of Allium cepa L. ...
  • 30. Jain S, Buttar HS, Chintameneni M, Kaur G. Prevention ...
  • 31. Tang GY, Meng X, Li Y, Zhao CN, Liu ...
  • 32. Thomson M, Alnaqeeb MA, Bordia T, Al-Hassan JM, Afzal ...
  • 33. Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Asghari-Jafarabadi M. Effects ...
  • 34. Kim J, Cha YJ, Lee KH, Park E. Effect ...
  • 35. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular ...
  • 36. Srinivasan K. Dietary spices as beneficial modulators of lipid ...
  • 37. Han SY, Hu Y, Anno T, Yanagita T. S-propyl ...
  • 38. Lee YG, Cho J, Hwang EJ, Jeon T, Moon ...
  • 39. Sun L, Li E, Wang F, Wang T, Qin ...
  • 40. Arteaga E, Villaseca P, Rojas A, Marshall G, Bianchi ...
  • 41. Bordia A, Arora SK, Kothari LK, Jain KC, Rathore ...
  • 42. Vidyavati HG, Manjunatha H, Hemavathy J, Srinivasan K. Hypolipidemic ...
  • 43. Kang HJ, Pichiah BT, Abinaya RV, Sohn HS, Cha ...
  • 44. Jaiswal N, Rizvi SI. Onion extract (Allium cepa L.), ...
  • 45. De Boer VCJ, Van Schothorst EM, Dihal AA, Van ...
  • 46. Yanagita T, Han S, Wang YM, Tsuruta Y, Anno ...
  • 47. Kumari K, Augusti KT. Lipid lowering effect of S-methyl ...
  • 48. Emamat H, Foroughi F, Eini-Zinab H, Hekmatdoost A. The ...
  • 49. Emamat H, Foroughi F, Eini-Zinab H, Taghizadeh M, Rismanchi ...
  • 50. Lu TM, Chiu HF, Shen YC, Chung CC, Venkatakrishnan ...
  • 51. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass ...
  • 52. Joo JK, Lee KS. Pharmacotherapy for obesity. J Menopausal ...
  • 53. Marrelli M, Amodeo V, Statti G, Conforti F. Biological ...
  • 54. Williams DJ, Edwards D, Hamernig I, Jian L, James ...
  • 55. Funakoshi T, Kanzaki N, Otsuka Y, Izumo T, Shibata ...
  • 56. Bae CR, Park YK, Cha YS. Quercetin-rich onion peel ...
  • 57. Seo MJ, Lee YJ, Hwang JH, Kim KJ, Lee ...
  • 58. Eseberri I, Miranda J, Lasa A, Churruca I, Portillo ...
  • 59. Yoshinari O, Shiojima Y, Igarashi K. Anti-Obesity Effects of ...
  • 60. Forney LA, Lenard NR, Stewart LK, Henagan TM. Dietary ...
  • 61. Pangeni R, Kang SW, Oak M, Park EY, Park ...
  • 62. Cypess AM, Lehman S, Williams G, Tal I, Rodman ...
  • 63. Lee SG, Parks JS, Kang HW. Quercetin, a functional ...
  • 64. Lee JS, Cha YJ, Lee KH, Yim JE. Onion ...
  • 65. Kim KA, Yim JE. The effect of onion peel ...
  • 66. Blacher J, Levy BI, Mourad JJ, Safar ME, Bakris ...
  • 67. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender ...
  • 68. Aslam M, Ahmad M, Mobasher F. Efficacy and tolerability ...
  • 69. Chen ZY, Peng C, Jiao R, Wong YM, Yang ...
  • 70. Oboh G, Ademiluyi AO, Agunloye OM, Ademosun AO, Ogunsakin ...
  • 71. Muhammad SA, Fatima N. In silico analysis and molecular ...
  • 72. Monori-Kiss A, Monos E, Nádasy GL. Quantitative analysis of ...
  • 73. Lodi F, Jimenez R, Moreno L, Kroon PA, Needs ...
  • 74. Brankovic S, Radenkovic M, Kitic D, Veljkovic S, Ivetic ...
  • 75. Naseri MKG, Arabian M, Badavi M, Ahangarpour A. Vasorelaxant ...
  • 76. Kawamoto E, Sakai Y, Okamura Y, Yamamoto Y. Effects ...
  • 77. Sakai Y, Murakami T, Yamamoto Y. Antihypertensive effects of ...
  • 78. Kivirantat J, Huovinen K, Seppänen‐Laakso T, Hiltunen R, Karppanen ...
  • 79. Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig ...
  • 80. Perez A, Gonzalez-Manzano S, Jimenez R, Perez-Abud R, Haro ...
  • 81. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons ...
  • 82. Kalus U, Pindur G, Jung F, Mayer B, Radtke ...
  • 83. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller ...
  • 84. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes ...
  • 85. American Diabetes Association. Microvascular complications and foot care: standards ...
  • 86. Kim HY, Kim K. Protein glycation inhibitory and antioxidative ...
  • 87. Jaiswal N, Rizvi SI. Amylase inhibitory and metal chelating ...
  • 88. Kim SH, Jo SH, Kwon YI, Hwang JK. Effects ...
  • 89. Schulze C, Bangert A, Schwanck B, Vollert H, Blaschek ...
  • 90. Gautam S, Pal S, Maurya R, Srivastava AK. Ethanolic ...
  • 91. Augusti KT. Effect of alloxan diabetes of allyl propyl ...
  • 92. Augusti KT, Roy VCM, Semple M. Effect of allyl ...
  • 93. Jain RC, Vyas CR. Letter: Hypoglycaemia action of onion ...
  • 94. Karawya MS, Abdel Wahab SM, El-Olemy MM, Farrag NM. ...
  • 95. Kumari K, Augusti KT. Antidiabetic effects of s-methylcysteine sulfoxide ...
  • 96. Ikechukwu OJ, Ifeanyi OS. The Antidiabetic effects of the ...
  • 97. Kook S, Kim GH, Choi K. The antidiabetic effect ...
  • 98. Devarshi PP, Jones AD, Taylor EM, Stefanska B, Henagan ...
  • 99. Snyder SM, Zhao B, Luo T, Kaiser C, Cavender ...
  • 100. Kaur G, Invally M, Chintamaneni M. Influence of piperine ...
  • 101. Al-Malki AL. inhibition of alpha-glucosidase by thiosulfinate as a ...
  • 102. Thomas S, Senthilkumar GP, Sivaraman K, Bobby Z, Paneerselvam ...
  • 103. Gomes IBS, Porto ML, Santos MCLFS, Campagnaro BP, Pereira ...
  • 104. Jung YS, Kim MH, Lee SH, Baik EJ, Park ...
  • 105. Fallah V, Mahabadi JA, Mahabadi MY, Kashani HH, Nikzad ...
  • 106. Bhanot A, Shri R. A comparative profile of methanol ...
  • 107. Jafarpour-Sadegh F, Montazeri V, Adili A, Esfehani A, Rashidi ...
  • 108. Taj Eldin IM, Ahmed EM, Elwahab HMA. Preliminary study ...
  • 109. Hoffman R, Ranjbar G, Madden AM. Inhibition of the ...
  • 110. Lee SM, Moon J, Cho Y, Chung JH, Shin ...
  • 111. Jung H, Wee JH, Kim K, Sung H, Shin ...
  • 112. Lata S, Saxena KK, Bhasin V, Saxena RS, Kumar ...
  • 113. Guan L, Chung HY, Su YL, Jiao R, Peng ...
  • 114. Sikder K, Das N, Kesh SB, Dey S. Quercetin ...
  • 115. Moon J, Do HJ, Kim OY, Shin MJ. Antiobesity ...
  • 116. Henagan TM, Cefalu WT, Ribnicky DM, Noland RC, Dunville ...
  • 117. Arias N, Picó C, Teresa Macarulla M, Oliver P, ...
  • 118. Vazquez-Prieto MA, Rodriguez Lanzi C, Lembo C, Galmarini CR, ...
  • 119. Gonzalez-Pena D, Angulo J, Vallejo S, Colina-Coca C, de ...
  • 120. Jalili T, Carlstrom J, Kim S, Freeman D, Jin ...
  • 121. Wu HR, Xu BJ. Inhibitory effects of onion against ...
  • 122. Ozougwu JC. Anti-diabetic effects of Allium cepa (onions) aqueous ...
  • 123. Babu PS, Srinivasan K. Influence of dietary capsaicin and ...
  • 124. El-Soud NA, Khalil M. Antioxidative effects of Allium cepa ...
  • 125. Ogunmodede OS, Saalu LC, Ogunlade B, Akunna GG, Oyewopo ...
  • 126. Jung JY, Lim Y, Moon MS, Kim JY, Kwon ...
  • 127. Arias N, MacArulla MT, Aguirre L, Martínez-Castaño MG, Portillo ...
  • 128. Anhê GF, Okamoto MM, Kinote A, Sollon C, Lellis-Santos ...
  • 129. Shetty AK, Rashmi R, Rajan MGR, Sambaiah K, Salimath ...
  • 130. Khaki A, Fathiazad F, Ahmadi-Ashtiani HR, Rezazadeh S, Rastegar ...
  • 131. G PS, Thomas S, K S, Sankar P, Bobby ...
  • 132. Choi EY, Lee H, Woo JS, Jang HH, Hwang ...
  • 133. Khorshidi M, Moini A, Alipoor E, Rezvan N, Gorgani-Firuzjaee ...
  • 134. Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig ...
  • 135. Nishimura M, Muro T, Kobori M, Nishihira J. Effect ...
  • 136. Bruell V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig ...
  • 137. Lee KH, Park E, Lee HJ, Kim MO, Cha ...
  • 138. Rezvan N, Moini A, Gorgani-Firuzjaee S, Hosseinzadeh-Attar MJ. Oral ...
  • Research Info Management

    Certificate | Report | من نویسنده این مقاله هستم

    اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

    Scientometrics

    The specifications of the publisher center of this Paper are as follows:
    Type of center: علوم پزشکی
    Paper count: 7,615
    In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

    Share this page

    More information about COI

    COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

    The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

    Support